Task: Answer Verification
Input (English): Question: Is doxorubicin administration by continuous infusion cardioprotective : the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol?
Answer: Continuous doxorubicin infusion over 48 hours for childhood leukemia did not offer a cardioprotective advantage over bolus infusion. Both regimens were associated with progressive subclinical cardiotoxicity. Other cardioprotective strategies should be explored.
Output (English): no